Rockwell Medical (RMTI) Research & Development (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Research & Development came in at $567000.0 in Q1 2026, down 20.25% YoY from $711000.0 in Q1 2025, and up 5.0% on a QoQ basis from $540000.0 in Q4 2025.
Rockwell Medical (RMTI) Research & Development (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Research & Development data on file, last reported at $567000.0 in Q1 2026.
- Quarterly Research & Development fell 20.25% year-over-year to $567000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (down 53.51% YoY) and the FY2025 annual result came in at $2.4 million, down 14.37% from the prior year.
- Research & Development climbed to $567000.0 in Q1 2026, from $540000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $2.7 million in Q4 2024 to a low of -$869000.0 in Q4 2022.
- A 5-year average of $564823.5 and a median of $531000.0 in 2025 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development plunged 401.74% — and 2024, when it soared 1596.27%.
- Tracing RMTI's Research & Development over 5 years: stood at -$869000.0 in 2022, then soared by 118.53% to $161000.0 in 2023, then soared by 1596.27% to $2.7 million in 2024, then sank by 80.23% to $540000.0 in 2025, then gained by 5.0% to $567000.0 in 2026.
- The last three Research & Development figures came in at $567000.0 (Q1 2026), $540000.0 (Q4 2025), and $531000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Rockwell Medical | 29.77 Mn | 4.98 Mn | 3.24 Mn | 577,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 577,000.00 |
| Mar 31, 2026 | 567,000.00 |
| Dec 31, 2025 | 540,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Jun 30, 2025 | 572,000.00 |
| Mar 31, 2025 | 711,000.00 |
| Dec 31, 2024 | 2.73 Mn |
| Sep 30, 2024 | 726,000.00 |
| Jun 30, 2024 | 586,000.00 |
| Mar 31, 2024 | 594,000.00 |
| Dec 31, 2023 | 161,000.00 |
| Sep 30, 2023 | 494,000.00 |
| Jun 30, 2023 | 530,000.00 |
| Mar 31, 2023 | 278,000.00 |
| Dec 31, 2022 | -869,000.00 |
| Sep 30, 2022 | 469,000.00 |
| Jun 30, 2022 | 526,000.00 |
| Mar 31, 2022 | 455,000.00 |
| Dec 31, 2021 | 288,000.00 |
| Sep 30, 2021 | 1.54 Mn |